Understanding bacterial biofilms in patients with cystic fibrosis: current and innovative approaches to potential therapies (Q35908307)

11 August 2017

1 reference

title

Understanding bacterial biofilms in patients with cystic fibrosis: current and innovative approaches to potential therapies (English)

1 reference

11 August 2017

0 references

0 references

1

Niels Høiby

0 references

author name string

Niels Høiby

series ordinal

1

1 reference

11 August 2017

1 December 2002

1 reference

Journal of Cystic Fibrosis

11 August 2017

1 reference

11 August 2017

1

1 reference

11 August 2017

4

1 reference

11 August 2017

249-254

1 reference

Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth

11 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Testing antimicrobial susceptibilities of adherent bacteria by a method that incorporates guidelines of the National Committee for Clinical Laboratory Standards.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Inhibition of tobramycin diffusion by binding to alginate

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Establishment of aging biofilms: possible mechanism of bacterial resistance to antimicrobial therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Antibiotic resistance of bacteria in biofilms

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Characterization of paired mucoid/non-mucoid Pseudomonas aeruginosa isolates from Danish cystic fibrosis patients: antibiotic resistance, beta-lactamase activity and RiboPrinting.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed beta-lactamase producing strains

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

High-level beta-lactamase activity in sputum samples from cystic fibrosis patients during antipseudomonal treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Oxidative stress in cystic fibrosis: dietary and metabolic factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Effect of oral N-acetylcysteine administration on human blood neutrophil and monocyte function

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Effects of inhaled gentamicin prophylaxis on acquisition of Pseudomonas aeruginosa in children with cystic fibrosis: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Extracellular DNA Required for Bacterial Biofilm Formation

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Erythromycin inhibits the production of elastase by Pseudomonas aeruginosa without affecting its proliferation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

New antimicrobials in the management of cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Cationic antimicrobial peptides: towards clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Specific phospholipids enhance the activity of beta-lactam antibiotics against Pseudomonas aeruginosa.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Alginate lyase promotes diffusion of aminoglycosides through the extracellular polysaccharide of mucoid Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

The efficacy of antibiotics enhanced by electrical currents against Pseudomonas aeruginosa biofilms

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

How Delisea pulchra furanones affect quorum sensing and swarming motility in Serratia liquefaciens MG1

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Effect of high-dose ibuprofen in patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Controlled Trial of Inhaled Budesonide in Patients with Cystic Fibrosis and Chronic BronchopulmonaryPseudomonas aeruginosaInfection

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Direct detection of N-acylhomoserine lactones in cystic fibrosis sputum.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Detection of Pseudomonas aeruginosa cell-to-cell signals in lung tissue of cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Detection of N-acylhomoserine lactones in lung tissues of mice infected with Pseudomonas aeruginosa.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

Pseudomonas aeruginosa mutations in lasI and rhlI quorum sensing systems result in milder chronic lung infection

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900104-2

7 January 2021

10.1016/S1569-1993(02)00104-2

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

15463822